Abstract:BACKGROUND AND AIMS: Syndromic biliary atresia is a cholangiopathy characterized by fibro-obliterative changes in the extrahepatic bile duct (EHBD) and congenital malformations including laterality defects. The aetiology remains elusive and faithful animal models are lacking. Genetic syndromes provide important clues for underlying pathogenic mechanisms of disease. We investigated the role of the gene Pkd1l1 in syndromic biliary atresia pathophysiology.METHODS: Constitutive and conditional Pkd1l1 knockout mice were generated to explore genetic pathology as a cause of syndromic biliary atresia. We assessed for congenital malformations, EHBD and liver pathology, EHBD gene expression, and biliary epithelial cell turnover. Biliary drainage was functionally assessed with cholangiography. Histology and serum chemistries were assessed after 3,5-diethoxycarbony l-1,4-dihydrocollidine (DDC) diet treatment and inhibition of the ciliary signalling effector GLI1.RESULTS: Pkd1l1-deficient mice exhibited congenital anomalies including malrotation and heterotaxy. Pkd1l1-deficient EHBD were hypertrophic and fibrotic. Pkd1l1-deficient EHBD were patent, but displayed delayed biliary drainage. Pkd1l1-deficient livers exhibited ductular reaction and periportal fibrosis. After DDC treatment, Pkd1l1-deficient mice exhibited EHBD obstruction and advanced liver fibrosis. Pkd1l1-deficient mice had increased expression of fibrosis and extracellular matrix remodeling genes (Tgfα, Cdkn1a, Hb-egf, Fgfr3, Pdgfc, Mmp12, and Mmp15) and decreased expression of genes mediating ciliary signalling (Gli1, Gli2, Ptch1, and Ptch2). Primary cilia were reduced on biliary epithelial cells and altered expression of ciliogenesis genes occurred in Pkd1l1-deficient mice. Small molecule inhibition of the ciliary signalling effector GLI1 with Gant61 recapitulated Pkd1l1-deficiency.CONCLUSIONS: Pkd1l1 loss causes both laterality defects and fibro-proliferative EHBD transformation through disrupted ciliary signalling, phenocopying syndromic biliary atresia. Pkd1l1-deficient mice function as an authentic genetic model to study biliary atresia pathogenesis.IMPACT AND IMPLICATIONS: The syndromic form of biliary atresia is characterized by fibro-obliteration of extrahepatic bile ducts and is often accompanied by laterality defects. The aetiology is unknown, but Pkd1l1 was identified as a potential genetic candidate for syndromic biliary atresia. We found that loss of the ciliary gene Pkd1l1 contributes to hepatobiliary pathology in biliary atresia, exhibited by bile duct hypertrophy, reduced biliary drainage, and liver fibrosis in Pkd1l1-deficient mice. Pkd1l1-deficient mice serve as a genetic model of biliary atresia and reveals ciliopathy as an aetiology of biliary atresia. This model will help scientists uncover new therapeutic approaches for patients with biliary atresia and validate screening for PKD1L1 variants by paediatric hepatologists for diagnostic evaluation.

Heterozygous calcyclin-binding protein/Siah1-interacting protein (CACYBP/SIP) gene pathogenic variant linked to a dominant family with paucity of interlobular bile duct

Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing

Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells

Inspissated Bile Syndrome in an Infant with Citrin Deficiency and Congenital Anomalies of the Biliary Tract and Esophagus: Identification and Pathogenicity Analysis of a Novel SLC25A13 Mutation with Incomplete Penetrance.

A SEC61A1 variant is associated with autosomal dominant polycystic liver disease

Two Novel Pathogenic Variants of TJP2 Gene and the Underlying Molecular Mechanisms in Progressive Familial Intrahepatic Cholestasis Type 4 Patients

Biallelic Loss-of-function ZFYVE19 Mutations Are Associated with Congenital Hepatic Fibrosis, Sclerosing Cholangiopathy and High-Ggt Cholestasis

A CYP11A1 homozygous exonic variant inducing an alternative splicing, frameshift and truncation in a family with congenital adrenal hyperplasia

Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations

The clinical phenotype with gastrostomy and abdominal wall infection in a pediatric patient with Takenouchi-Kosaki syndrome due to a heterozygous c.191A > G (p.Tyr64Cys) variant in CDC42: a case report

A Novel Compound Heterozygous Mutation in ABCB4 Gene in a Pedigree with Progressive Familial Intrahepatic Cholestasis 3: a Case Report.

A novel splicing mutation DNAH5 c.13,338 + 5G > C is involved in the pathogenesis of primary ciliary dyskinesia in a family with primary familial brain calcification

Liver cyst gene knockout in cholangiocytes inhibits cilium formation and Wnt signaling

Low-GGT Intrahepatic Cholestasis Associated with Biallelic USP53 Variants: Clinical, Histological and Ultrastructural Characterization

Case Report: A Novel Missense Variant in the SIPA1L3 Gene Associated With Cataracts in a Chinese Family

Two Novel Pathogenic Variants of <i>TJP2</i> Gene and the Underlying Molecular Mechanisms in Progressive Familial Intrahepatic Cholestasis Type 4 Patients

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

Biallelic variants in SLC26A2 cause multiple epiphyseal dysplasia-4 by disturbing chondrocyte homeostasis

Clinical heterogeneity and intrafamilial variability of Joubert syndrome in two siblings with <i>CPLANE1</i> variants

The First Korean Adult Case of Progressive Familial Intrahepatic Cholestasis Type 7 with Novel USP53 Splicing Variants by Next Generation Sequencing

Characterizing A Novel Variant in ABCB1 in a Family with Activated PI3K Delta Syndrome-like Presentation